Text Size
71 studies found for:    Open Studies | "Urinary Bladder, Overactive"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Study of Overactive Bladder in Women With Prolapse
Conditions: Urinary Bladder, Overactive;   Pelvic Organ Prolapse
Intervention: Other: Pre- and postoperative evaluations
2 Recruiting Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Unilateral electrode placement and testing;   Procedure: Bilateral electrode placement and testing
3 Recruiting A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug
Condition: Urinary Bladder, Overactive
Interventions: Drug: Solifenacin succinate;   Drug: Placebo;   Behavioral: Urotherapy
4 Recruiting Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
Condition: Overactive Bladder Syndrome
Intervention: Drug: Solifenacin
5 Recruiting Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Conditions: Overactive Bladder;   Lower Urinary Tract Symptoms
Interventions: Behavioral: Behavioral training;   Drug: Tolterodine + tamsulosin
6 Recruiting Bladder Thermal Distention for Patients With Refractory Overactive Bladder
Condition: Overactive Bladder
Intervention: Procedure: Bladder Thermal Distention
7 Recruiting Bacterial Genomic Sequencing in Overactive Bladder
Condition: Overactive Bladder
Intervention: Drug: Solifenacin
8 Not yet recruiting Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder
Condition: Overactive Bladder
Interventions: Other: PTNS plus solifenacin;   Other: Placebo
9 Unknown † Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
Conditions: Urinary Urge;   Urge Incontinence;   Overactive Bladder
Interventions: Drug: solifenacin succinate;   Drug: placebo
10 Not yet recruiting Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Solifenacin;   Drug: Oxybutynin
11 Recruiting Painless Laser Therapy for Overactive Bladder
Condition: Overactive Bladder
Intervention: Device: LCT-1000TM (Manufacturer: LiteCure)
12 Unknown † Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Tolterodine extended-release (ER) 4mg;   Drug: Placebo
13 Recruiting Comparative Urine Proteomic Studies of Overactive Bladder in Humans
Condition: Overactive Bladder
Intervention: Drug: fesoterodine
14 Recruiting Peripheral Electrical Stimulation for the Treatment of Overactive Bladder
Condition: Idiopathic Overactive Bladder
Intervention: Procedure: Transcutaneous Electrical Nerve Stimulation
15 Unknown † Grouptraining for Overactive Bladder in Adults
Condition: Overactive Bladder
Interventions: Behavioral: bladdertraining in groups;   Behavioral: bladdertraining individually
16 Recruiting Therapy of the Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: solifenacin;   Procedure: PFMT and WBVT
17 Recruiting Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
Conditions: Parkinson's Disease;   Overactive Bladder
Intervention: Drug: Oxybutynin and darifenacin
18 Recruiting Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: Liposome encapsulated botulinum toxin A;   Drug: Normal saline instillation
19 Recruiting Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: Detrusitol 4mg QD and Oxybutynin ER 5mg QD;   Drug: Detrusitol 4mg QD
20 Recruiting A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
Condition: Overactive Bladder Associated With HTLV-1
Interventions: Drug: Propantheline Bromide;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years